Curcumin (diferuloylmethane) inhibits receptor activator of NF-kappa B ligand-induced NF-kappa B activation in osteoclast precursors and suppresses osteoclastogenesis. [electronic resource]
- Journal of immunology (Baltimore, Md. : 1950) May 2004
- 5940-7 p. digital
Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.; Research Support, U.S. Gov't, P.H.S.
0022-1767
10.4049/jimmunol.172.10.5940 doi
Animals Bone Marrow Cells--cytology Carrier Proteins--antagonists & inhibitors Cell Differentiation--drug effects Cell Line Coated Pits, Cell-Membrane--drug effects Curcumin--pharmacology Enzyme Inhibitors--pharmacology Growth Inhibitors--pharmacology I-kappa B Kinase I-kappa B Proteins--antagonists & inhibitors Macrophages--cytology Membrane Glycoproteins--antagonists & inhibitors Mice NF-KappaB Inhibitor alpha NF-kappa B--antagonists & inhibitors Osteoclasts--cytology Phosphorylation--drug effects Protein Serine-Threonine Kinases--antagonists & inhibitors RANK Ligand Receptor Activator of Nuclear Factor-kappa B Signal Transduction--drug effects Stem Cells--cytology